Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: Evaluation by selective depletion of low-density lipoproteins or fibrinogen

被引:26
作者
Otto, C [1 ]
Richter, WO [1 ]
Schwandt, P [1 ]
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Med 2, D-81366 Munich, Germany
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2000年 / 49卷 / 06期
关键词
D O I
10.1053/meta.2000.6264
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epidemiological studies suggest that the plasma fibrinogen concentration is the main determinant of plasma viscosity (PV), but the concentration of other macromolecules leg, immunoglobulins) and low-density lipoprotein (LDL) cholesterol and triglycerides are also correlated with PV. However, only a few data exist concerning the in vitro effects of these plasma constituents on PV. Therefore, we investigated PV before and after the specific elimination of fibrinogen and LDL in hypercholesterolemic and hypertriglyceridemic plasma. First, hypercholesterolemic samples (n = 7) were pumped simultaneously through 2 columns: a fibrinogen-depleting column containing the pentapeptide Gly-Pro-Arg-Pro-Lys (GPRPK) and a LDL-depleting column containing specific antibodies against apolipoprotein B-100. In the plasma and in each fraction from the column, the cholesterol level was measured enzymatically, fibrinogen was determined by immunonephelometry, and PV was analyzed using a low-shear rotation viscosimeter. After the fibrinogen-depleting column, the fibrinogen concentration decreased from 3.21 +/- 0.20 to 0.94 +/- 0.16 g/L (P < .005), inducing a decrease in PV from 1.27 +/- 0.02 to 1.17 +/- 0.01 mPas (milliPascal seconds) (P < .005). Despite a marked reduction of the LDL cholesterol after the LDL-depleting column (from 6.40 +/- 0.23 to 4.08 +/- 0.32 mmol/L,P < .005), PV remained unchanged. Second, hypertriglyceridemic samples (n = 7) were pumped through the fibrinogen-depleting column, which reduced the fibrinogen concentration from 4.29 +/- 0.79 to 1.62 +/- 0.69 g/L (P < .001) and PV from 1.42 +/- 0.06 to 1.03 +/- 0.05 mPas (P < .01) while the triglyceride concentration remained unchanged. Our results confirm the epidemiological correlation between the fibrinogen concentration and PV in patients with hypercholesterolemia and hypertriglyceridemia. The influence of fibrinogen on PV seems much more pronounced than the direct effect of lipoprotein concentrations. Therefore, the elevated PV in patients with hypercholesterolemia and especially with hypertriglyceridemia seems mainly due to elevated fibrinogen levels. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:810 / 813
页数:4
相关论文
共 18 条
[1]   PLASMA-FIBRINOGEN LEVELS AND THEIR CORRELATES IN 6457 CORONARY HEART-DISEASE PATIENTS - THE BEZAFIBRATE INFARCTION PREVENTION (BIP) STUDY [J].
BARASCH, E ;
BENDERLY, M ;
GRAFF, E ;
BEHAR, S ;
REICHERREISS, H ;
CASPI, A ;
PELLED, B ;
REISIN, L ;
ROGUIN, N ;
GOLDBOURT, U ;
SCHLESINGER, Z ;
FRIDENSOHN, A ;
JAFARI, J ;
SCLAROVSKY, S ;
FRIEDMAN, Y ;
OSTFELD, B ;
ABINADER, E ;
ROCHFLEISH, S ;
PALANT, A ;
SCHNEIDER, H ;
ROSENFELD, T ;
KHALID, S ;
KISHON, Y ;
ROTZAK, R ;
ZAHAVI, I ;
VITRAI, J ;
PARDU, J ;
LANIADO, S ;
SHERF, L ;
BRAUN, S ;
ESCHAR, Y ;
ARDITI, A ;
BOTWIN, S ;
DAVID, D ;
WEISNENBERG, D ;
GLUSMAN, A ;
MARKIEWICZ, W ;
MOTLAK, D ;
MARMOUR, A ;
FLICH, M ;
ZION, M ;
BALKIN, J ;
RABINOWITZ, B ;
KRISTAL, N ;
LIEL, N .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (06) :757-765
[2]   FIBRINOGEN AND FIBRINOLYTIC VARIABLES IN RELATION TO ANTHROPOMETRY, LIPIDS AND BLOOD-PRESSURE - THE NORTHERN SWEDEN MONICA STUDY [J].
ELIASSON, M ;
EVRIN, PE ;
LUNDBLAD, D .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (05) :513-524
[3]   CHOLESTEROL IN THE PREDICTION OF ATHEROSCLEROTIC DISEASE - NEW PERSPECTIVES BASED ON THE FRAMINGHAM STUDY [J].
KANNEL, WB ;
CASTELLI, WP ;
GORDON, T .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) :85-91
[4]   ASSOCIATION BETWEEN RHEOLOGY AND COMPONENTS OF LIPOPROTEINS IN HUMAN BLOOD - RESULTS FROM THE MONICA PROJECT [J].
KOENIG, W ;
SUND, M ;
ERNST, E ;
MRAZ, W ;
HOMBACH, V ;
KEIL, U .
CIRCULATION, 1992, 85 (06) :2197-2204
[5]  
KUYAS C, 1990, THROMB HAEMOSTASIS, V63, P439
[6]   STUDIES ON SYNTHETIC PEPTIDES THAT BIND TO FIBRINOGEN AND PREVENT FIBRIN POLYMERIZATION - STRUCTURAL REQUIREMENTS, NUMBER OF BINDING-SITES, AND SPECIES-DIFFERENCES [J].
LAUDANO, AP ;
DOOLITTLE, RF .
BIOCHEMISTRY, 1980, 19 (05) :1013-1019
[7]   PLASMA-FIBRINOGEN AND CORONARY RISK-FACTORS - THE SCOTTISH HEART HEALTH STUDY [J].
LEE, AJ ;
SMITH, WCS ;
LOWE, GDO ;
TUNSTALLPEDOE, H .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (09) :913-919
[8]   STUDIES OF PLASMA VISCOSITY IN PRIMARY HYPERLIPOPROTEINEMIA [J].
LEONHARDT, H ;
ARNTZ, HR ;
KLEMENS, UH .
ATHEROSCLEROSIS, 1977, 28 (01) :29-40
[9]   BLOOD-VISCOSITY, LIPOPROTEINS, AND CARDIOVASCULAR RISK [J].
LOWE, GDO .
CIRCULATION, 1992, 85 (06) :2329-2331
[10]  
LOWE GDO, 1992, THROMB HAEMOSTASIS, V67, P494